Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New concepts in immunotherapy.

J W Willoughby1

  • 1School of Medicine, University of Missouri, Kansas City.

Otolaryngologic Clinics of North America
|February 1, 1992
PubMed
Summary

Optimizing allergen immunotherapy requires personalized dosing based on individual patient responses. Monitoring allergen-specific IgG levels helps identify optimal doses and relevant allergens for effective treatment, minimizing adverse reactions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serum concentrations of allergen-specific IgG antibodies in inhalant allergy: effect of specific immunotherapy.

American journal of clinical pathology·1983
Same author

Measurement of plasma histamine in patients with suspected food hypersensitivity.

Annals of allergy·1981
Same author

Serial dilution titration skin tests in inhalant allergy: A clinical quantitative assessment of biologic skin reactivity to allergenic extracts.

Otolaryngologic clinics of North America·1974
Same author

Letter: Committee on provocative food testing data strengthens validity of provocative subcutaneous food test technique.

Annals of allergy·1973
Same author

Provocative food test technique.

Annals of allergy·1965
Same author

THE DIAGNOSIS OF FOOD ALLERGY.

Archives of otolaryngology (Chicago, Ill. : 1960)·1964

Area of Science:

  • Allergy and Immunology
  • Immunotherapy
  • Pharmacology

Background:

  • Various routes and forms of allergen immunotherapy have demonstrated efficacy in producing blocking antibodies and improving symptoms.
  • Determining a universal optimal maintenance dose for allergen immunotherapy is not feasible due to individual patient variability.
  • Allergen immunotherapy administration carries a risk of adverse reactions, including anaphylaxis, which can be mitigated by careful dose escalation.

Purpose of the Study:

  • To investigate the variability in optimal immunotherapeutic doses among patients undergoing allergen immunotherapy.
  • To explore the role of allergen-specific IgG monitoring in optimizing immunotherapy regimens.
  • To identify factors contributing to immunotherapy treatment failures.

Main Methods:

  • Review of immunotherapy routes (injection, intranasal, oral) and extract types (lyophilized, aqueous, glycerinated, modified).
  • Analysis of patient responses to varying doses of allergenic extracts, including Amb a I (ragweed AgE).
  • Monitoring of allergen-specific IgG levels during immunotherapy to assess treatment effectiveness and guide dose adjustments.

Main Results:

  • Individual patient requirements for optimal immunotherapy doses (AU/mL or weight/volume) vary significantly.
  • Not all patients tolerate or require the same optimal immunotherapeutic dose.
  • Inadequate treatment dose potency or omission of relevant allergens can lead to immunotherapy failure.
  • Allergen-specific IgG monitoring provides an objective measure to guide safe escalation of immunotherapy dose potency.

Conclusions:

  • Personalized dosing strategies are essential for effective allergen immunotherapy.
  • Allergen-specific IgG monitoring is a valuable tool for optimizing immunotherapy by identifying appropriate allergens and safe dose escalation.
  • Tailoring immunotherapy to individual patient needs can improve treatment outcomes and reduce the risk of adverse events.

Related Experiment Videos